English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  53305860    線上人數 :  749
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"shao y y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 351-396 / 396 (共8頁)
<< < 1 2 3 4 5 6 7 8 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2018-09-10T05:45:46Z Emergency department presentation of chronic peritoneal dialysis patients Pai, M.-F.;Hsu, S.-P.;Peng, Y.-S.;Chiang, C.-K.;Ho, T.-I.;Shao, Y.Y.;Lee, H.-Y.;Hung, K.-Y.; CHIH-KANG CHIANG
臺大學術典藏 2017 Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells Shao Y.-Y.;Min-Shu Hsieh;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; Shao Y.-Y.; MIN-SHU HSIEH; Wang H.-Y.; Li Y.-S.; Lin H.; Hsu H.-W.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2017 Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells Lin H.; Shao Y.-Y.;Hsieh M.-S.;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Hsieh M.-S.; Wang H.-Y.; Li Y.-S.; Hsu H.-W.; Huang C.-Y.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2017 Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC) Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Morikawa H.; Maki Y.; Tanaka T.; Ohtomo T.; Schwartz L.; Smith-Jones P.M.; Frenette C.; O’Neil B.; Shao Y.-Y.; Wan P.; Ma J.; Gansukh B.; Lyashchenko S.K.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Yen C.-J.; CHIH-HUNG HSU; Abou-Alfa G.K.; Abou-Alfa G.K.;Yen C.-J.;Chih-Hung Hsu;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Shao Y.-Y.;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Lin Z.-Z.
臺大學術典藏 2017 Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Shao Y.-Y.;Bang-Bin Chen;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; Shao Y.-Y.; BANG-BIN CHEN; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏 2017 Right or left? Side selection for a totally implantable vascular access device: A randomised observational study Hsu C.-H; Lin C.-P; WEN-YING LIN; Lee Y.-H; Lin Y.-T; Hsu M.-C; Shao Y.-Y.
國立成功大學 2017 Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC) Abou-Alfa, G.K.;Yen, C.-J.;Hsu, C.-H.;O’Donoghue, J.;Beylergil, V.;Ruan, S.;Pandit-Taskar, N.;Gansukh, B.;Lyashchenko, S.K.;Ma, J.;Wan, P.;Shao, Y.-Y.;Lin, Z.-Z.;Frenette, C.;O’Neil, B.;Schwartz, L.;Smith-Jones, P.M.;Ohtomo, T.;Tanaka, Tanaka T.;Morikawa, H.;Maki, Y.;Ohishi, N.;Chen, Y.-C.;Agajanov, T.;Boisserie, F.;Di, Laurenzio L.;Lee, R.;Larson, S.M.;Cheng, A.-L.;Carrasquilo, J.A.
國立成功大學 2017 Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan Shen, W.-C.;Chen, J.-S.;Shao, Y.-Y.;Lee, K.-D.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Liao, Y.-M.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Chou, W.-C.;Hsieh, R.-K.
國立臺灣大學 2016 Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿
國立成功大學 2015-12-01 A clinical survey on satisfaction of pain management in hospitalized patients with cancer in Taiwan Lin, J.; Chang, C. -S.; Lee, M. -Y.; Liao, Y. -M.; Wu, M. -F.; Sung, Y. -C.; Rau, K. -M.; Yu, M. -S.; Lai, P. -Y.; Chiou, T. -J.; Chen, J. -S.; Lee, K. -D.; Hwang, W. -L.; Liu, T. -C.; Yen, C. -J.; Shao, Y. -Y.; Hsieh, R. -K.
國立成功大學 2015-12-01 Impact and predictive factor of undertreatment of analgesic drug in outpatients with cancer: a nationwide of clinical pain survey in Taiwan Yang, C. -K.; Chou, W. -C.; Shen, W. -C.; Chen, J. -S.; Lee, K. -D.; Yen, C. -J.; Lai, P. -Y.; Shao, Y. -Y.; Hwang, W. -L.; Chiou, T. -J.; Sung, Y. -C.; Rau, K. -M.; Liao, Y. -M.; Chang, C. S.; Wu, M. -F.; Lee, M. -Y.; Yu, M. -S.; Liu, T. -C.; Hsieh, R. -K.
臺大學術典藏 2015 The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2015 Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there? Shao Y.-Y.; CHIH-HUNG HSU; Cheng A.-L.; Shao Y.-Y.;Chih-Hung Hsu;Cheng A.-L.
臺大學術典藏 2015 Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.; Yeh Y.-C.; Chen H.-M.; Yeh K.-H.; Shao Y.-Y.; CHIH-HUNG HSU; Shao Y.-Y.;Chih-Hung Hsu;Yeh K.-H.;Chen H.-M.;Yeh Y.-C.;Lai C.-L.;Lin Z.-Z.;Cheng A.-L.;Lai M.-S.
臺大學術典藏 2015 High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib Lin T.-H.;Shao Y.-Y.;Chan S.-Y.;Huang C.-Y.;Chih-Hung Hsu;Cheng A.-L.; Lin T.-H.; Shao Y.-Y.; Chan S.-Y.; Huang C.-Y.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2015 Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Shao Y.-Y.;Shau W.-Y.;Chan S.-Y.;Lu L.-C.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; Lu L.-C.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2014 β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; CHIH-HUNG HSU; Lu L.-C.; Lu L.-C.;Shao Y.-Y.;Lee Y.-H.;Hsieh M.-S.;Hsiao C.-H.;Lin H.-H.;Kao H.-F.;Ma Y.-Y.;Yen F.-C.;Cheng A.-L.;Chih-Hung Hsu
臺大學術典藏 2013 A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏 2013 Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU; Cheng A.-L.
實踐大學 2012 Protective effect of antrosterol from Antrodia camphorata submerged whole broth against carbon tetrachloride-induced acute liver injury in mice Huang, G.J.;Deng, J.S.;Huang, S.S.;Shao, Y.Y.;Chen, C.C.;Kuo, Y.H.
國立臺灣大學 2012 HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2012 Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿
國立臺灣大學 2012 LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書
臺大學術典藏 2012 Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2012 Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2012 Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lai M.-S.
實踐大學 2011 Ficuschlorins A-D, Lactone Chlorins from the Leaves of Ficus microcarpa Lin, H.Y.;Chiu, H.L.;Lan, Y.H.;Tzeng, C.Y.;Lee, T.H.;Lee, C.K.;Shao, Y.Y.;Chen, C.R.;Chang, C.I.;Kuo, Y.H.
實踐大學 2011 Ficusmicrochlorin A-C, Two New Methoxy Lactone Chlorins and an Anhydride Chlorin from the Leaves of Ficus microcarpa Lin, H.Y.;Chiu, H.L.;Lu, T.L.;Tzeng, C.Y.;Lee, T.H.;Lee, C.K.;Shao, Y.Y.;Chen, C.R.;Chang, C.I.;Kuo, Y.H.
臺大學術典藏 2011 High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; CHIUN HSU; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
實踐大學 2010 Analgesic Effects and the Mechanisms of Anti-inflammation of Ergostatrien-3 beta-ol from Antrodia camphorata Submerged Whole Broth in Mice Huang, G.J.;Huang, S.S.;Lin, S.S.;Shao, Y.Y.;Chen, C.C.;Hou, W.C.;Kuo, Y.H.
臺大學術典藏 2010 Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Cheng A.-L.; Kuo W.-H.; Chiun Hsu; Liau J.-Y.; Lee W.-C.; Huang C.-S.; Lu Y.-S.; Hu F.-C.; Kuo K.-T.; Shao Y.-Y.; Shao Y.-Y.;Kuo K.-T.;Hu F.-C.;Lu Y.-S.;Huang C.-S.;Liau J.-Y.;Lee W.-C.;Chiun Hsu;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Chang K.-J.; Lin C.-H.
國立成功大學 2009-05-30 Using ADV backscatter strength for measuring suspended cohesive sediment concentration Ha, H. K.; Hsu, W. Y.; Maa, Jerome P. Y.; Shao, Y. Y.; Holland, C. W.
實踐大學 2009 Effects of heat and enzyme treatments on functional properties of commercial whey protein concentrate Shao, Y.Y.;Kao, Y.J.
實踐大學 2008 Chemical constituents of Antrodia camphorata submerged whole broth Shao, Y.Y.;Chen, C.C.;Wang, H.Y.;Chiu, H.L.;Hseu, T.H.;Kuo, Y.H.
實踐大學 2008 EFFECTS OF STEAMING AND KNEADING WITH PRESTEAMING TREATMENTS ON THE PHYSICOCHEMICAL PROPERTIES OF VARIOUS GENOTYPES OF SWEET POTATO (IPOMOEA BATATAS L.) Shao, Y.Y.;Huang, Y.C.
國立臺灣大學 2008 Three new triterpenes from the roots of Rhus javanica L. var. roxburghiana Chiu, C. L.; Lee, T. H.; Shao, Y. Y.; Kuo, Y. H.
國立臺灣大學 2008 Chemical constituents of Antrodia camphorata submerged whole broth Shao, Y. Y.; Chen, C. C.; Wang, H. Y.; Chiu, H. L.; Hseu, T. H.; Kuo, Y. H.
實踐大學 2007 New Lignans from the heartwood of Cunninghamia lanceolata Lee, T.H.;Yeh, M.H.;Chang, C.I.;Lee, C.K.;Shao, Y.Y.;Ku, Y.H.
實踐大學 2007 Rheological properties of rice amylose gels and their relationships to the structures of amylose and its subfractions Shao, Y.Y.;Tseng, Y.H.;Chang, Y.H.;Lin, J.H.;Lii, C.Y.
實踐大學 2006 Neuroprotective diterpenes from the fruiting body of Antrodia camphorata Chen, C.C.;Shiao, Y.J.;Lin, R.D.;Shao, Y.Y.;Lai, M.N.;Lin, C.C.;Ng, L.T.;Kuo, Y.H.
實踐大學 2006 Calocedimers A, B, C, and D from the bark of Calocedrus macrolepis var. formosana Hsieh, C.L.;Shiu, L.L.;Tseng, M.H.;Shao, Y.Y.;Kuo, Y.H.
實踐大學 2006 C-35 terpenoids from the bark of Calocedrus macrolepis var. formosana with activity against human cancer cell lines Hsieh, C.L.;Tseng, M.H.;Shao, Y.Y.;Chang, J.Y.;Kuo, C.C.;Chang, C.Y.;Kuo, Y.H.
實踐大學 2006 Effects of genotype and treatment on the antioxidant activity of sweet potato in Taiwan Huang, Y.C.;Chang, Y.H.;Shao, Y.Y.
實踐大學 2006 New constituents from the heartwood of Picea morrisonicola Hayata Lee, T.H.;Yeh, M.H.;Chang, C.I.;Lee, C.K.;Shao, Y.Y.;Kuo, Y.H.
國立臺灣大學 2006 Neuroprotective diterpenes from the fruiting body of Antrodia camphorata Chen, C.C.; Shiao, Y. J.; Lin, R. D.; Shao, Y. Y.; Lai, M. N.; Lin, C. C.; Ng, L. T.; Kuo, Y. H.
實踐大學 2002 Effect of resistant starch on plasma and liver lipids in rats Shao, Y.Y.

顯示項目 351-396 / 396 (共8頁)
<< < 1 2 3 4 5 6 7 8 
每頁顯示[10|25|50]項目